NIAID Funding News, March 3, 2021

March 3, 2021 NIAID Funding News Read this full edition online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices Feature Articles  Highlights From January 2021 NIAID Advisory Council Meeting In his opening remarks to NIAID's Advisory Council on January 25, 2021, NIAID Director Dr. Anthony Fauci shared key staff transitions, legislative updates, and COVID-19 news. Opportunities and Resources Act Now To CounterACT Chemical Threats NIAID is now participating in four funding opportunity announcements related to the Countermeasures Against Chemical Threats (CounterACT) program, a component under the NIH-wide Chemical Countermeasures Research Program. Expand Basic Research of Non-Polio Human Enteroviruses NIAID issued a new funding opportunity announcement to advance basic research for non-polio human enteroviruses and inform future vaccine and therapeutic development against enteroviruses A, B, C, and D. In The News Summary of Salary Cap and Stipend Levels for Fiscal Year 2021 Learn about the fiscal year 2021 salary cap and stipend levels for National Research Service Awards, which NIH published in January. NIH's COVID-19 Website Shares Vaccine News and Clinical Trial Resources Check out NIH's new website to follow the latest COVID-19 scientific and research findings, clinical trial volunteer guidance, grant funding data, and vaccine and treatment news. Recent Winter Storms Prompt NIH Natural Disaster Policy If your institution was closed due to the severity of recent winter storms, explain the cause of submission delay in your cover letter and NIH will consider accepting it late. Reminder—Respond to Key Immunologic Events RFI by March 15 Send feedback in response to NIAID's request for information (RFI) on identification of key events in autoimmune diseases. Advice Corner How a Subaward Can Supplement Your Research Activities A subaward is a collaborative arrangement between a grantee institution and another organization in support of the grantee's research project. The subawardee performs research activities on behalf of the grantee. Reader Questions "What kinds of projects are suitable for a small research grant?" "How can I apply for an R56-Bridge award?" New Funding Opportunities NOT-OD-21-070, Notice of Special Interest (NOSI)—Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows Development of Medical Countermeasures for Biothreat Agents, Antimicrobial-Resistant Infections an Emerging Infectious Diseases NIAID Clinical Site Monitoring Center (CSMC) NOT-EB-21-001, Notice of Special Interest (NOSI)—Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health RFA-AI-21-007, Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33, Clinical Trial Not Allowed) RFA-DK-21-005, Immune Cell Engineering for Targeted Therapy and Disease Monitoring in Type 1 Diabetes (R01, Clinical Trial Not Allowed) RFA-AI-21-022, Limited Competition—Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20, Clinical Trial Not Allowed) PAR-21-120, Global Infectious Disease Research Training Program (D43, Clinical Trial Optional) Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, March 3, 2021 — Add Comment